FDA, Drug Ads

The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...
Executives and directors of Agenus Inc. misled the public about the results of clinical trials for the biotech’s cancer ...
President-elect Donald Trump has named Robert F. Kennedy Jr. as his choice for the next secretary of the Department of Health ...
Newsweek magazine delivered to your door Newsweek Voices: Diverse audio opinions Enjoy ad-free browsing on Newsweek.com Comment on articles Newsweek app updates on-the-go ...
The U.S. Food and Drug Administration has published the 2022 ... The Food Code and the Supplement are joint projects by the FDA, the Centers for Disease Control and Prevention, and the ...
Oct 17 - The U.S. Food and Drug Administration has approved Avadel ... approved for the same condition as Lumryz, Xywav has the FDA's expanded nod to treat idiopathic hypersomnia, a rare ...
today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to Papillon’s PPL-001, an experimental treatment for Friedreich's ataxia.
Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...